Walker Neal's Form 4 filing
Aclaris Therapeutics, Inc. (ACRS) · filed Mar 3, 2023
- Accession no.
- 0001209191-23-016074
- Filed
- Mar 3, 2023
- Trade date
- Mar 1-3, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $740.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Walker NealCIK 0001604457 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | Common Stock | MOption exerciseAcquired | +96,150 | – | – | 1,271,913 | Direct | |
| Mar 1, 2023 | Common Stock | MOption exerciseAcquired | +18,275 | – | – | 1,290,188 | Direct | |
| Mar 1, 2023 | Common Stock | MOption exerciseAcquired | +24,000 | – | – | 1,314,188 | Direct | |
| Mar 2, 2023 | Common Stock | SSaleDisposed | −29,000 | $12.37 | −$358,730 | 1,285,188 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseAcquired | +18,254 | – | – | 1,303,442 | Direct | |
| Mar 3, 2023 | Common Stock | SSaleDisposed | −30,240 | $12.63 | −$381,931.2 | 1,273,202 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | Common Stock | MOption exerciseDisposed | −96,150 | $0.00 | $0 | 0 | Direct | |
| Mar 1, 2023 | Common Stock | MOption exerciseDisposed | −18,275 | $0.00 | $0 | 36,550 | Direct | |
| Mar 1, 2023 | Common Stock | MOption exerciseDisposed | −24,000 | $0.00 | $0 | 72,000 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseDisposed | −18,254 | $0.00 | $0 | 18,254 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.